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Table 1 Tryptic products of in vitro n-BSA



















TVM* ENFVAFVDK 2 95.00% 71.6 38 5.02 708.3477 1,414.68 1,415.69 -0.0004417
IETM*REKVLTSSAR 3 64.20% 0 0 1.31 546.623 1,636.85 1,636.87 0.9842
DAFLGSFLYEY*SR 2 95.00% 41.8 38.3 5.48 806.8712 1,611.73 1,612.73 0.006302
LGEY*GFQNALIVR 2 95.00% 86.9 38.6 8.09 762.8956 1,523.78 1,524.78 0.002306
RHPEY*AVSVLLR 3 95.00% 47.5 38.8 4.57 495.6044 1,483.79 1,484.80 0.0003256
Y*LYEIAR 2 65.50% 29.8 36.6 0 486.7436 971.4716 972.4791 0.0004075
YLY*EIAR 2 68.90% 30.5 36.6 0 486.7436 971.4716 972.4791 0.0004075
Y*LY*EIAR 2 85.30% 35.6 36.5 0 509.2361 1,016.46 1,017.46 0.0003306
AEFVEVTK 2 95.00% 54.1 35.9 0 461.7474 921.4792 922.4886 -0.001529
AEFVEVTK 1 85.60% 43.3 35.9 0 922.4875 921.4797 922.4886 -0.001053
AEFVEVTKLVTDLTK 2 95.00% 0 0 3.44 847.9707 1,693.93 1,692.94 1.991
AFDEK 2 74.70% 29.8 34.4 0 305.1478 608.28 609.2885 -0.0006331
ATEEQLK 1 76.10% 27.9 36.3 0 818.4245 817.4167 818.4261 -0.001546
ATEEQLK 2 95.00% 51.1 36.3 0 409.7164 817.4172 818.4261 -0.001022
CCTKPESER 2 95.00% 64.7 36.6 1.48 526.7297 1,051.44 1,052.45 0.001065
CCTKPESER 3 95.00% 30.8 36.6 2 351.489 1,051.44 1,052.45 0.0008892
DAFLGSFLYEYSR 2 95.00% 79 38.3 8.03 784.3771 1,566.74 1,567.74 0.003179
DAFLGSFLYEYSRR 3 95.00% 26.8 45.6 1.74 575.2875 1,722.84 1,723.84 0.002598
DAIPENLPPLTADFAEDK 2 95.00% 50.8 46.3 5 978.4852 1,954.95 1,955.96 0.002055
DLGEEHFK 2 95.00% 51.1 36.6 0 487.7336 973.4516 974.4585 0.0009688
DTHKSEIAHR 3 95.00% 43.9 43.9 1.7 398.5388 1,192.59 1,193.60 -0.001902
FKDLGEEHFK 2 95.00% 59.3 37.6 3.72 625.3146 1,248.61 1,249.62 -0.0004376
FKDLGEEHFK 3 95.00% 59.6 37.6 3.96 417.2124 1,248.61 1,249.62 -0.0002136
FKDLGEEHFK 4 95.00% 27.5 37.5 1.29 313.1605 1,248.61 1,249.62 -0.00319
FPKAEFVEVTK 2 68.50% 0 0 1.85 648.3491 1,294.68 1,294.70 0.9857
FPKAEFVEVTK 3 95.00% 27.3 38.1 1.12 432.2374 1,293.69 1,294.70 -0.008115
FQNALLVR 2 93.50% 44.8 44 0 480.7861 959.5566 960.5631 0.001377
HLVDEPQNLIK 2 95.00% 52.2 38.1 5.66 653.3591 1,304.70 1,305.72 -0.006416
HLVDEPQNLIK 3 95.00% 39.1 38.1 1.27 435.9096 1,304.71 1,305.72 -0.003592
HPEYAVSVLLR 2 95.00% 40.1 38.1 2.08 642.3597 1,282.70 1,283.71 0.0004832
HPEYAVSVLLR 3 95.00% 47.3 38.1 3.68 428.5756 1,282.70 1,283.71 0.0001072
IETMR 1 58.40% 18.1 34.9 0 649.3345 648.3267 649.3344 0.0001521
IETMR 2 77.10% 31 34.9 0 325.1712 648.3268 649.3344 0.0002761
KQTALVELLK 2 95.00% 77 38.8 0 571.8612 1,141.71 1,142.72 -0.0004154
KQTALVELLK 3 95.00% 58.5 38.8 0 381.5762 1,141.71 1,142.72 -0.001991
KVPQVSTPTLVEVSR 2 95.00% 94.1 39.8 7.64 820.4717 1,638.93 1,639.94 -0.002713
KVPQVSTPTLVEVSR 3 95.00% 76.8 39.8 5.64 547.319 1,638.93 1,639.94 0.003111
LCVLHEK 2 95.00% 47 35.7 0 421.232 840.4484 841.4607 -0.004421
LGEYGFQNALIVR 2 95.00% 85.2 38.8 5.66 740.4017 1,478.79 1,479.80 -0.0004167
LSQKFPK 2 95.00% 43.7 36.5 0 424.2566 846.4976 847.5043 0.001177
LSQKFPKAEFVEVTK 3 95.00% 0 0 2.59 584.9897 1,751.95 1,750.97 1.979
LSQRFPK 2 93.40% 43.9 43.2 0 438.2521 874.4886 875.5104 -0.01393
LVNELTEFAK 1 95.00% 33.6 37.4 4.31 1,163.63 1,162.62 1,163.63 -0.001753
LVNELTEFAK 2 95.00% 74.4 37.4 2.82 582.3201 1,162.62 1,163.63 0.001171
HAGCEK 3 95.00% 34.7 40.1 2.54 832.05 2,493.13 2,494.16 -0.02511
LVTDLTK 1 79.70% 34.6 36.3 0 789.4715 788.4637 789.4724 -0.0008407
LVTDLTK 2 95.00% 53.2 36.3 0 395.2392 788.4628 789.4724 -0.001717
LVVSTQTALA 2 95.00% 68.3 37.2 3.44 501.795 1,001.57 1,002.58 -0.001308
QTALVELLK 2 95.00% 77.3 37.6 0 507.8132 1,013.61 1,014.62 -0.001414
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Table 1 (continued)



















RHPEYAVSVLLR 2 95.00% 0 0 4.51 720.9116 1,439.81 1,439.81 1.003
RHPEYAVSVLLR 3 95.00% 83.1 38.9 4.43 480.6088 1,438.80 1,439.81 -0.001398
SLHTLFGDELCK 2 95.00% 27.9 44.4 1.74 681.8406 1,361.67 1,362.67 0.000476
TCVADESHAGCEK 2 95.00% 66.3 37.7 6.1 675.2777 1,348.54 1,349.55 0.000973
TCVADESHAGCEK 3 95.00% 44 37.8 2.57 450.5207 1,348.54 1,349.55 -0.000103
TPVSEKVTK 2 95.00% 72.7 43.8 4.43 494.7871 987.5586 988.568 -0.001521
TVMENFVAFVDK 2 95.00% 70.1 38.1 3.43 700.3507 1,398.69 1,399.69 0.0004733
VASLR 2 78.80% 33.1 36.5 0 273.1742 544.3328 545.3411 -0.0004225
VPQVSTPTLVEVSR 2 95.00% 102 39.2 7.68 756.4266 1,510.84 1,511.84 0.002089







































































































C) Total L-PGDS Total NO2-Modified L-PGDS
Total NO2-Modified CSF Protein
IP: L-PGDS
Slot Blot:













IP: Nitrotyrosine Western Blot: 1 Ab: Anti-Nitrotyrosine(monoclonal)





















Fig. 4 1-D electrophoresis (a) of nitrotyrosine enrichment fractions
from pooled non-HIV (control) and HAND CSF. Lane 1, MW marker;
lane 2, flowthrough (non-nitrated proteins); lane 3, pre-elution PBS
wash; and lane 4, 5% formic acid elution (enriched nitrated proteins).
The total number of spectra acquired (normalized spectrum count)
from Non-HIV (control) and HAND CSF nitrotyrosine-modified
subproteome (a). Quantitative immunoblot analysis of nitrotyrosine
content in albumin/IgG-depleted non-HIV (control) and HAND
(diseased) CSF (b) and L-PGDS (c) determined by slot blot analysis
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